Bionano Genomics, Inc. Accounts Payable
Bionano Genomics, Inc. (BNGO) had Accounts Payable of $4.56 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $4.56M.
- 2026-03-31: Accounts Payable, Current $5.06M.
- 2025-12-31: Accounts Payable, Current $5.59M.
- 2025-09-30: Accounts Payable, Current $5.99M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.56M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $5.06M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.59M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $5.99M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.24M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.56M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $6.96M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $8.70M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $8.73M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $9.84M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $10.38M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $15.37M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $11.91M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $15.78M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $12.53M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $9.41M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $7.70M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $6.59M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $10.77M 10-K · filed 2023-03-09 | $9.70M 10-K · filed 2022-03-01 |
| 2021-09-30 | $7.88M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.75M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $2.21M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.93M 10-K · filed 2022-03-01 | $2.93M 10-K · filed 2021-03-23 |
| 2020-09-30 | $5.67M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $2.85M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $3.18M 10-Q · filed 2020-06-18 | |
| 2019-12-31 | $2.70M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $2.63M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.62M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $870.84K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.35M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $2.36M 10-Q · filed 2018-11-07 | |
| 2017-12-31 | $2.30M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |